KEYS vs QNRX · P/E 57, rev $5.16B vs $9.6M cap
Keysight Technologies Inc (KEYS) versus Quoin Pharmaceuticals Ltd DRC (QNRX) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
QNRX does not have a complete income-statement cache yet.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. QNRX currently screens at market cap $9.6M.
Not investment advice. Open the KEYS and QNRX stock pages for the full models.
Not investment advice.